← Back
Data updated: Mar 10, 2026
CASPER PHARMA LLC
Infectious DiseaseOncologyCardiovascular
CASPER PHARMA LLC is a major pharmaceutical company focused on Infectious Disease, Oncology, Cardiovascular.
1949
Since
16
Drugs
-
Trials
11
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ROBINUL 2026-02-24
Labeling
ROBINUL 2025-09-25
Manufacturing (CMC)
CORTISPORIN 2025-08-08
Labeling
CORTISPORIN 2025-08-08
Labeling
CORTISPORIN 2025-08-08
Labeling
ROBINUL 2025-07-16
Efficacy
HELIDAC 2025-03-31
Labeling
ROBINUL 2024-07-12
Manufacturing (CMC)
IMURAN 2024-07-09
Labeling
IMURAN 2024-07-09
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 25%
2 drugs Phase 3: 1 Phase 2: 2
Oncology 25%
1 drugs Phase 3: 3 Phase 1: 2
Cardiovascular 22%
3 drugs
Gastroenterology 15%
2 drugs
Dermatology 14%
1 drugs Phase 3: 1 Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Gastroenterology
Active (9)
Discontinued (7)
Company Info
- First Approval
- 1949-05-18
- Latest
- 2025-03-31
- Applications
- 15